Lisa Bero

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint The power of paperwork: how Philip Morris neutralized the medical code for secondhand smoke
    Daniel M Cook
    Center for Tobacco Control Research and Education, University of California, San Francisco UCSF, USA
    Health Aff (Millwood) 24:994-1004. 2005
  2. ncbi request reprint Managing financial conflicts of interest in research
    Lisa A Bero
    Department of Clinical Pharmacy and Health Policy, University of California, San Francisco, USA
    J Am Coll Dent 72:4-9. 2005
  3. ncbi request reprint Framing processes in public commentary on US federal tobacco control regulation
    Andrew L Roth
    Institute for Health Policy Studies, University of California, San Francisco, 94143, USA
    Soc Stud Sci 33:7-44. 2003
  4. pmc Science in regulatory policy making: case studies in the development of workplace smoking restrictions
    L A Bero
    Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California San Francisco, San Francisco, CA 94142 0936, USA
    Tob Control 10:329-36. 2001
  5. pmc The limits of competing interest disclosures
    L A Bero
    Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco, San Francisco, California, USA
    Tob Control 14:118-26. 2005
  6. pmc Tobacco industry manipulation of research
    Lisa A Bero
    Department of Clinical Pharmacy, School of Pharmacy, Institute for Health Policy Studies, University of California, San Francisco 94143, USA
    Public Health Rep 120:200-8. 2005
  7. ncbi request reprint Implications of the tobacco industry documents for public health and policy
    Lisa Bero
    Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco, California 94143 0613, USA
    Annu Rev Public Health 24:267-88. 2003
  8. ncbi request reprint Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds
    Jenny White
    Department of Clinical Pharmacy, University of California, San Francisco, CA, USA
    Nicotine Tob Res 9:1213-25. 2007
  9. ncbi request reprint Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy
    K G Shojania
    Department of Medicine, University of California, San Francisco, San Francisco, Calif, USA
    Eff Clin Pract 4:157-62. 2001
  10. pmc Cigars, youth, and the Internet link
    R E Malone
    Institute for Health Policy Studies, School of Medicine, University of California, San Francisco 94143, USA
    Am J Public Health 90:790-2. 2000

Research Grants

Collaborators

Detail Information

Publications56

  1. ncbi request reprint The power of paperwork: how Philip Morris neutralized the medical code for secondhand smoke
    Daniel M Cook
    Center for Tobacco Control Research and Education, University of California, San Francisco UCSF, USA
    Health Aff (Millwood) 24:994-1004. 2005
    ..Philip Morris's reaction reveals the importance of policy decisions related to data collection and paperwork...
  2. ncbi request reprint Managing financial conflicts of interest in research
    Lisa A Bero
    Department of Clinical Pharmacy and Health Policy, University of California, San Francisco, USA
    J Am Coll Dent 72:4-9. 2005
    ..Differences of opinion exist in the research community over whether disclosure of financial interests, although necessary, is sufficient to ensure a reasonable level of freedom from bias and to maintain public trust...
  3. ncbi request reprint Framing processes in public commentary on US federal tobacco control regulation
    Andrew L Roth
    Institute for Health Policy Studies, University of California, San Francisco, 94143, USA
    Soc Stud Sci 33:7-44. 2003
    ..An orientation to the dynamics of framing and counter-framing contributes to an understanding of the relationship between scientific evidence and public commentary in the formulation of controversial health policy regulations...
  4. pmc Science in regulatory policy making: case studies in the development of workplace smoking restrictions
    L A Bero
    Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California San Francisco, San Francisco, CA 94142 0936, USA
    Tob Control 10:329-36. 2001
    ..To study the role of science related and other arguments in the development of workplace smoking regulations...
  5. pmc The limits of competing interest disclosures
    L A Bero
    Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco, San Francisco, California, USA
    Tob Control 14:118-26. 2005
    ....
  6. pmc Tobacco industry manipulation of research
    Lisa A Bero
    Department of Clinical Pharmacy, School of Pharmacy, Institute for Health Policy Studies, University of California, San Francisco 94143, USA
    Public Health Rep 120:200-8. 2005
  7. ncbi request reprint Implications of the tobacco industry documents for public health and policy
    Lisa Bero
    Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco, California 94143 0613, USA
    Annu Rev Public Health 24:267-88. 2003
    ..The paper concludes with a discussion of the implications of tobacco document research for public health and the application of such research to fields other than tobacco control...
  8. ncbi request reprint Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds
    Jenny White
    Department of Clinical Pharmacy, University of California, San Francisco, CA, USA
    Nicotine Tob Res 9:1213-25. 2007
    ..Policymakers should consider expanding the scope of federal human subjects research regulations to cover research undertaken by private firms such as tobacco companies...
  9. ncbi request reprint Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy
    K G Shojania
    Department of Medicine, University of California, San Francisco, San Francisco, Calif, USA
    Eff Clin Pract 4:157-62. 2001
    ..Unfortunately, the few published strategies for identifying these articles involve MEDLINE interfaces not widely available outside of academic medicine. In addition, the performance of these strategies is unknown...
  10. pmc Cigars, youth, and the Internet link
    R E Malone
    Institute for Health Policy Studies, School of Medicine, University of California, San Francisco 94143, USA
    Am J Public Health 90:790-2. 2000
    ..This study examined the accessibility and appeal to youth of cigar marketing sites on the Internet...
  11. pmc Scientific quality of original research articles on environmental tobacco smoke
    D E Barnes
    Institute for Health Policy Studies, School of Medicine, University of California, San Francisco 94109, USA
    Tob Control 6:19-26. 1997
    ....
  12. doi request reprint Medicaid drug selection committees and inadequate management of conflicts of interest
    Nicole Yvonne Nguyen
    Department of Clinical Pharmacy and Institute for Health Policy Studies, University of California, San Francisco, 3333 California St, San Francisco, CA 94118, USA
    JAMA Intern Med 173:338-43. 2013
    ....
  13. doi request reprint Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses
    BETH HART
    Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco, 3333 California St, Suite 420, San Francisco, CA 94118, USA
    BMJ 344:d7202. 2012
    ..To investigate the effect of including unpublished trial outcome data obtained from the Food and Drug Administration (FDA) on the results of meta-analyses of drug trials...
  14. pmc Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation
    Kristin Rising
    School of Medicine, University of California San Francisco, San Francisco, California, USA
    PLoS Med 5:e217; discussion e217. 2008
    ....
  15. doi request reprint "Experimental" institutional models for corporate funding of academic research: unknown effects on the research enterprise
    Lisa Bero
    University of California, Clinical Pharmacy and Health Policy, 3333 California Street, Suite 420, San Francisco, CA, USA
    J Clin Epidemiol 61:629-33. 2008
  16. pmc Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others
    Lisa Bero
    Clinical Pharmacy and Health Policy, University of California, San Francisco, California, United States of America
    PLoS Med 4:e184. 2007
    ....
  17. pmc Policy makers' perspectives on tobacco control advocates' roles in regulation development
    T Montini
    Department of Social and Behavioral Sciences, and Institute for Health Policy Studies, University of California, San Francisco, California 94143-0936, USA
    Tob Control 10:218-24. 2001
    ..CONCLUSIONS: There is an important role for tobacco control advocates in the policy development process in regulatory agencies...
  18. doi request reprint Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes
    Nancy Nkansah
    University of California San Francisco, 155 North Fresno Street Suite 224, Fresno, CA 93701, USA
    Public Health Nutr 12:1931-7. 2009
    ..To explore the relationship between industry sponsorship of Ca supplementation studies in healthy children and study outcomes...
  19. doi request reprint An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences
    Tracey J Woodruff
    University of California, San Francisco, CA, USA
    Health Aff (Millwood) 30:931-7. 2011
    ..The methodology can also support professional societies, health care organizations, government agencies, and others in developing prevention-oriented guidelines for use in clinical and policy settings...
  20. pmc Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala
    Angela Anson
    Department of Clinical Pharmacy, University of California, San Francisco, CA 94143 0622, USA
    Global Health 8:22. 2012
    ..A first step in achieving this goal is to obtain a baseline measure of access to essential medicines. The objective of this project was to measure the availability, prices, and affordability of children's medicines in Guatemala...
  21. pmc To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008
    Lisa Bero
    Department of Clinical Pharmacy, University of California, 3333 California Street Suite 420, San Francisco, CA 94118, United States of America
    Bull World Health Organ 88:922-9. 2010
    ..to assess drug donations in terms of their adherence to the drug donation guidelines put forth by the World Health Organization (WHO)...
  22. ncbi request reprint Financial ties and conflicts of interest between pharmaceutical and tobacco companies
    Bhavna Shamasunder
    Institute for Health Policy Studies, University of California, San Francisco, USA
    JAMA 288:738-44. 2002
    ..Thus, because tobacco cessation product marketing has been altered as a result of these financial conflicts, disclosure would serve the interest of public health...
  23. ncbi request reprint Characteristics of materials distributed by drug companies. An evaluation of appropriateness
    D Stryer
    Kayenta Health Center, Indian Health Service, San Francisco, CA, USA
    J Gen Intern Med 11:575-83. 1996
    ..The material contains both educational and promotional characteristics...
  24. pmc Cigar magazines: using tobacco to sell a lifestyle
    L D Wenger
    Institute for Health Policy Studies, University of California, San Francisco, San Francisco, California 94143-0936, USA
    Tob Control 10:279-84. 2001
    ..Public health advocates should anticipate and challenge other new tobacco marketing vehicles as communications technologies advance and public spaces for smoking shrink...
  25. pmc Characteristics and impact of drug detailing for gabapentin
    Michael A Steinman
    Affairs Medical Center, San Francisco, California, United States of America
    PLoS Med 4:e134. 2007
    ..In this study, we evaluated the content and impact of detail visits for gabapentin by analyzing market research forms completed by physicians after receiving a detail visit for this drug...
  26. pmc The creation of industry front groups: the tobacco industry and "get government off our back"
    Dorie E Apollonio
    Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA 94143, USA
    Am J Public Health 97:419-27. 2007
    ..Those who seek to establish measures to protect public health should be prepared to counter the argument that government should not regulate private behavior...
  27. ncbi request reprint Identifying carcinogens: the tobacco industry and regulatory politics in the United States
    Daniel M Cook
    Department of Clinical Pharmacy, Institute for Health Policy Studies, University of California, San Francisco 94143, USA
    Int J Health Serv 36:747-66. 2006
    ..However, the tobacco industry's participation in the regulatory process influenced the process in favor of all regulated industry...
  28. ncbi request reprint Evaluating public commentary and scientific evidence submitted in the development of a risk assessment
    Marieka S Schotland
    Department of Clinical Pharmacy and Institute for Health Policy Studies, University of California, San Francisco 94143 0936, USA
    Risk Anal 22:131-40. 2002
    ..Critics and supporters of the risk assessment used different criteria to evaluate the scientific evidence, suggesting that they were socially constructing the evidence to support their positions...
  29. ncbi request reprint Defining financial conflicts and managing research relationships: an analysis of university conflict of interest committee decisions
    Elizabeth A Boyd
    Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA 94143 0613, USA
    Sci Eng Ethics 13:415-35. 2007
    ....
  30. ncbi request reprint Narrative review: the promotion of gabapentin: an analysis of internal industry documents
    Michael A Steinman
    San Francisco Veterans Affairs Medical Center and University of California, San Francisco, San Francisco, California 94143, USA
    Ann Intern Med 145:284-93. 2006
    ..Such documents have become available through litigation concerning the promotion of gabapentin (Neurontin, Pfizer, Inc., New York, New York) for off-label uses...
  31. pmc Tobacco interests or the public interest: 20 years of industry strategies to undermine airline smoking restrictions
    Peggy Lopipero
    Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, California 94143 0613, USA
    Tob Control 15:323-32. 2006
    ..To understand the evolution of 20 years of tobacco industry strategies to undermine federal restrictions of smoking on aircraft in the United States...
  32. ncbi request reprint Tobacco industry sponsorship of a book and conflict of interest
    Mi Kyung Hong
    Department of Clinical Pharmacy and Center for Tobacco Control Research and Education, University of California, San Francisco, CA, USA
    Addiction 101:1202-11. 2006
    ..The objective of this study is to examine tobacco industry involvement in the development of scientific books...
  33. pmc Tobacco use among individuals with schizophrenia: what role has the tobacco industry played?
    Judith J Prochaska
    Department of Psychiatry, University of California, San Francisco, CA 94143 0984, USA
    Schizophr Bull 34:555-67. 2008
    ....
  34. ncbi request reprint Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals
    Kirby P Lee
    University of California, San Francisco, CA, USA
    Med J Aust 184:621-6. 2006
    ..To identify characteristics of submitted manuscripts that are associated with acceptance for publication by major biomedical journals...
  35. pmc Tobacco industry efforts to defeat the occupational safety and health administration indoor air quality rule
    Katherine Bryan-Jones
    Department of Clinical Pharmacy and Institute for Health Policy Studies, University of California San Francisco, 94143 1390, USA
    Am J Public Health 93:585-92. 2003
    ..We describe tobacco industry strategies to defeat the Occupational Safety and Health Administration (OSHA) Indoor Air Quality rule and the implementation of those strategies...
  36. pmc Assessing the evidence submitted in the development of a workplace smoking regulation: the case of Maryland
    Theresa Montini
    Department of Social and Behavioral Sciences and Institute for Health Policy Studies, University of California at San Francisco, San Francisco, CA 94143, USA
    Public Health Rep 117:291-8. 2002
    ....
  37. ncbi request reprint Impact of a collaborative pharmacy practice model on the treatment of depression in primary care
    Patrick R Finley
    Department of Clinical Pharmacy, School of Pharmacy, University of California at San Francisco UCSF, San Francisco, USA
    Am J Health Syst Pharm 59:1518-26. 2002
    ....
  38. ncbi request reprint High school journalists' perspectives on tobacco
    Ruth E Malone
    Department of Social and Behavioral Sciences, School of Nursing, University of California, San Francisco 94143, USA
    J Health Commun 7:139-56. 2002
    ..Youth journalists should also be included in media advocacy efforts...
  39. pmc Pharmaceutical industry sponsorship and research outcome and quality: systematic review
    Joel Lexchin
    School of Health Policy and Management, York University, Toronto, ON, Canada M3J 1P3
    BMJ 326:1167-70. 2003
    ....
  40. ncbi request reprint Financial conflict-of-interest policies in clinical research: issues for clinical investigators
    Elizabeth A Boyd
    Department of Clinical Pharmacy, University of California, San Francisco, 94143, USA
    Acad Med 78:769-74. 2003
    ....
  41. ncbi request reprint Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial
    Patrick R Finley
    Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, California 94143 0622, USA
    Pharmacotherapy 23:1175-85. 2003
    ..Clinical pharmacists had a favorable effect on multiple aspects of patient care. Future studies of this model in other health care settings appear warranted...
  42. pmc Public health under attack: the American Stop Smoking Intervention Study (ASSIST) and the tobacco industry
    Jenny White
    Department of Clinical Pharmacy, Center for Tobacco Control Research and Education, University of California, San Francisco 94143, USA
    Am J Public Health 94:240-50. 2004
    ..This evidence suggest that tobacco control advocates should expect a vigorous response from the tobacco industry to policy advocacy efforts, particularly at the local level...
  43. ncbi request reprint Implementation of financial disclosure policies to manage conflicts of interest
    Elizabeth A Boyd
    University of California, San Francisco, Department of Clinical Pharmacy, USA
    Health Aff (Millwood) 23:206-14. 2004
    ..Our study suggests the importance of local culture and context for institutional decision making...
  44. ncbi request reprint Comparison of review articles published in peer-reviewed and throwaway journals
    Paula A Rochon
    Kunin Lunenfeld Applied Research Unit, Baycrest Centre for Geriatric Care, Department of Medicine, University of Toronto, Toronto, Ontario, Canada M6A 2E1
    JAMA 287:2853-6. 2002
    ..To compare the quality, presentation, readability, and clinical relevance of review articles published in peer-reviewed and "throwaway" journals...
  45. ncbi request reprint Conflicts of interest in academic research: policies, processes, and attitudes
    Shira Lipton
    University of California, Los Angeles, Los Angeles, CA, USA
    Account Res 11:83-102. 2004
    ....
  46. ncbi request reprint Association of journal quality indicators with methodological quality of clinical research articles
    Kirby P Lee
    Institute for Health Policy Studies, School of Medicine, University of California, San Francisco, CA, USA
    JAMA 287:2805-8. 2002
    ..The ability to identify scientific journals that publish high-quality research would help clinicians, scientists, and health-policy analysts to select the most up-to-date medical literature to review...
  47. ncbi request reprint Legislating "sound science": the role of the tobacco industry
    Annamaria Baba
    Department of Clinical Pharmacy, University of California, San Francisco, 3333 California Street, Suite 420, Box 0613, San Francisco, CA 94143, USA
    Am J Public Health 95:S20-7. 2005
    ..The tobacco industry played a role in establishing laws that increase corporate influence on public health and regulatory policy decisions...
  48. pmc How the tobacco industry responded to an influential study of the health effects of secondhand smoke
    Mi Kyung Hong
    Department of Clinical Pharmacy and Institute for Health Policy Studies, University of California, Box 0613, San Francisco, CA 94143 0613, USA
    BMJ 325:1413-6. 2002
  49. ncbi request reprint Effect of telephone follow-up on the physical well-being dimension of quality of life in patients with cancer
    Johnny Beney
    Institut central des hôpitaux valaisans, Sion Switzerland
    Pharmacotherapy 22:1301-11. 2002
    ..To evaluate the effect of telephone follow-up on the physical well-being dimension of health-related quality of life in patients with cancer...
  50. pmc "Developing good taste in evidence": facilitators of and hindrances to evidence-informed health policymaking in state government
    Christopher J Jewell
    University of California, San Francisco 94143 0613, USA
    Milbank Q 86:177-208. 2008
    ..The real-life context in which policymakers are situated and make decisions also is crucial to the development of evidence-informed policy...
  51. pmc Reporting science and conflicts of interest in the lay press
    Daniel M Cook
    School of Public Health, University of Nevada, Reno, Nevada, United States of America
    PLoS ONE 2:e1266. 2007
    ..Forthright reporting of financial ties and conflicts of interest of researchers is associated with public trust in and esteem for the scientific enterprise...
  52. pmc Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study
    Veronica Yank
    Stanford University, Stanford Medical Group, Stanford, CA 94305 5765, USA
    BMJ 335:1202-5. 2007
    ..To determine whether financial ties to one drug company are associated with favourable results or conclusions in meta-analyses on antihypertensive drugs...
  53. ncbi request reprint Attitudes of academic and clinical researchers toward financial ties in research: a systematic review
    Bonnie E Glaser
    University of California, San Francisco, CA 94143 0613, USA
    Sci Eng Ethics 11:553-73. 2005
    ..However, their trust in disclosure as a way to manage conflicts may reveal a lack of awareness of the actual impact of financial incentives on themselves and other researchers...
  54. ncbi request reprint Evidence based medicine: increasing, not dictating, choice
    Kay Dickersin
    Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, 615 N Wolfe Street, Baltimore, MD 21205, USA
    BMJ 334:s10. 2007
  55. ncbi request reprint The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study
    Nancy Thai Nguyen
    Clionical Pharmacy and Health Policy, University of California San Francisco, 3333 Ca lifornia Street, San Francisco, CA 94143, USA
    Clin Ther 28:1231-43. 2006
    ..The US Food and Drug Administration (FDA) and FDA advisory committees have been under increasing scrutiny as a result of media attention to safety concerns...
  56. ncbi request reprint Prevalence of honorary and ghost authorship in Cochrane reviews
    Graham Mowatt
    Health Services Research Unit, University of Aberdeen, Polwarth Bldg, Foresterhill, Aberdeen AB25 2ZD, Scotland
    JAMA 287:2769-71. 2002
    ..To determine the prevalence of honorary and ghost authorship in Cochrane reviews, how authorship is assigned, and the ways in which authors and Cochrane editorial teams contribute...

Research Grants4

  1. A Qualitative Study of Editorial Decision-Making
    Lisa Bero; Fiscal Year: 2003
    ..abstract_text> ..
  2. Management Decisions in Financial Conflicts of Interest
    Lisa Bero; Fiscal Year: 2002
    ..Our findings will allow us to develop a framework for decision-making regarding conflict identification and management. ..